214 related articles for article (PubMed ID: 12243462)
1. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs.
Zemke D; Yamini B; Yuzbasiyan-Gurkan V
Vet Pathol; 2002 Sep; 39(5):529-35. PubMed ID: 12243462
[TBL] [Abstract][Full Text] [Related]
2. A study of mutations in the c-kit gene of 32 dogs with mastocytoma.
Riva F; Brizzola S; Stefanello D; Crema S; Turin L
J Vet Diagn Invest; 2005 Jul; 17(4):385-8. PubMed ID: 16131001
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs.
Downing S; Chien MB; Kass PH; Moore PE; London CA
Am J Vet Res; 2002 Dec; 63(12):1718-23. PubMed ID: 12492288
[TBL] [Abstract][Full Text] [Related]
4. Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis.
Jones CL; Grahn RA; Chien MB; Lyons LA; London CA
J Vet Diagn Invest; 2004 Mar; 16(2):95-100. PubMed ID: 15053358
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
6. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms.
Ma Y; Longley BJ; Wang X; Blount JL; Langley K; Caughey GH
J Invest Dermatol; 1999 Feb; 112(2):165-70. PubMed ID: 9989791
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
8. DNA purification increases PCR-amplifiable DNA extracted from formalin-fixed, paraffin-embedded canine mast cell tumors for routine
Tamlin VS; Dobson EC; Woolford L; Peaston AE
J Vet Diagn Invest; 2019 Sep; 31(5):756-760. PubMed ID: 31378162
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours.
Amagai Y; Tanaka A; Matsuda A; Jung K; Oida K; Nishikawa S; Jang H; Matsuda H
J Small Anim Pract; 2013 Jul; 54(7):377-80. PubMed ID: 23614673
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
London CA; Galli SJ; Yuuki T; Hu ZQ; Helfand SC; Geissler EN
Exp Hematol; 1999 Apr; 27(4):689-97. PubMed ID: 10210327
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-kit proto-oncogene in canine mastocytoma: a kinetic study using real-time polymerase chain reaction.
Turin L; Acocella F; Stefanello D; Oseliero A; Fondrini D; Brizzola S; Riva F
J Vet Diagn Invest; 2006 Jul; 18(4):343-9. PubMed ID: 16921872
[TBL] [Abstract][Full Text] [Related]
12. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
Ohmori K; Kawarai S; Yasuda N; Tanaka A; Matsuda H; Nishimura R; Sasaki N; Tsujimoto H; Masuda K
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):43-53. PubMed ID: 18687474
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an intron deletion in the c-kit gene of canine mast cell tumors.
Reguera MJ; Ferrer L; Rabanal RM
Am J Vet Res; 2002 Sep; 63(9):1257-61. PubMed ID: 12224856
[TBL] [Abstract][Full Text] [Related]
15. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
16. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats.
Dank G; Chien MB; London CA
Am J Vet Res; 2002 Aug; 63(8):1129-33. PubMed ID: 12171166
[TBL] [Abstract][Full Text] [Related]
18. Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline.
Marconato L; Zorzan E; Giantin M; Di Palma S; Cancedda S; Dacasto M
J Vet Intern Med; 2014; 28(2):547-53. PubMed ID: 24372836
[TBL] [Abstract][Full Text] [Related]
19. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
20. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
Meyer A; Gruber AD; Klopfleisch R
Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
